Treatment of infantile spasms: why do we know so little?

References

• Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522–530.
   PubMed Web of Science ®Google Scholar
• Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):512–521.
   PubMed Web of Science ®Google Scholar
• Wilmshurst JM, Ibekwe RC, O’Callaghan FJK. Epileptic spasms — 175 years on: trying to teach an old dog new tricks. Seizure. 2017;44:81–86.
   PubMed Web of Science ®Google Scholar
• Riikonen R, Donner M. Incidence and aetiology of infantile spasms from 1960 to 1976: a Population Study in Finland. Dev Med Child Neurol. 2008;21(3):333–343.
   Google Scholar
• Cowan LD, Hudson LS. The epidemiology and natural history of infantile spasms. J Child Neurol. 1991;6(4):355–364.
   PubMed Web of Science ®Google Scholar
• Sidenvall R, Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia. 1995;36(6):572–574.
   PubMed Web of Science ®Google Scholar
• Durá-Travé T, Yoldi-Petri ME, Gallinas-Victoriano F. Incidence of epilepsies and epileptic syndromes among children in Navarre, Spain: 2002 through 2005. J Child Neurol. 2008;23(8):878–882.
   PubMed Web of Science ®Google Scholar
• Berg AT, Coryell J, Saneto RP, et al. Early-life epilepsies and the emerging role of genetic testing. JAMA Pediatr. 2017;171(9):863.
   PubMed Web of Science ®Google Scholar
• Vigevano F, Fusco L, Pachatz C. Neurophysiology of spasms. Brain Dev. 2001;23(7):467–472.
   PubMed Web of Science ®Google Scholar
• Fusco L, Vigevano F. Ictal clinical electroencephalographic findings of spasms in west syndrome. Epilepsia. 1993;34(4):671–678.
   PubMed Web of Science ®Google Scholar
• Hrachovy RA, Frost JD, Kellaway P. Hypsarrhythmia: variations on the Theme. Epilepsia. 1984;25(3):317–325.
   PubMed Web of Science ®Google Scholar
• Donat JF, Lo WD. Asymmetric hypsarrhythmia and infantile spasms in west syndrome. J Child Neurol. 1994;9(3):290–296.
   PubMed Web of Science ®Google Scholar
• Kramer U, Sue WC, Mikati MA. Hypsarrhythmia: frequency of variant patterns and correlation with etiology and outcome. Neurology. 1997;48(1):197–203.
   PubMed Web of Science ®Google Scholar
• Caraballo RH, Fortini S, Reyes G, et al. Epileptic spasms in clusters and associated syndromes other than West syndrome: A study of 48 patients. Epilepsy Res. 2016;123:29–35.
   PubMed Web of Science ®Google Scholar
• Osborne JP, Lux AL, Edwards SW, et al., The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification2. Epilepsia. 2010;51(10):2168–2174. .
   PubMed Web of Science ®Google Scholar
• Riikonen RS. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol. 2010;14(1):13–18.
   PubMed Web of Science ®Google Scholar
• Yamada K, Toribe Y, Kimizu T, et al. Predictive value of EEG findings at control of epileptic spasms for seizure relapse in patients with West syndrome. Seizure. 2014;23(9):703–707.
   PubMed Web of Science ®Google Scholar
• Gaily E, Lommi M, Lapatto R, et al. Incidence and outcome of epilepsy syndromes with onset in the first year of life: A retrospective population-based study. Epilepsia. 2016;57(10):1594–1601.
   PubMed Web of Science ®Google Scholar
• Smith RJ, Ombao HC, Shrey DW, et al. Inference on long-range temporal correlations in human EEG data. IEEE J Biomed Heal Informatics. 2020;24(4):1070–1079.
   PubMed Web of Science ®Google Scholar
• Japaridze N, Muthuraman M, Moeller F, et al. Neuronal networks in west syndrome as revealed by source analysis and renormalized partial directed coherence. Brain Topogr. 2013;26(1):157–170.
   PubMed Web of Science ®Google Scholar
• Siniatchkin M, Moeller F, Jacobs J, et al. Spatial filters and automated spike detection based on brain topographies improve sensitivity of EEG–fMRI studies in focal epilepsy. Neuroimage. 2007;37(3):834–843.
   PubMed Web of Science ®Google Scholar
• Chugani HT, Shewmon DA, Sankar R, et al., Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography. Ann Neurol. 1992;31(2):212–219. .
   PubMed Web of Science ®Google Scholar
• Chiron C, Dulac O, Bulteau C, et al. Study of regional cerebral blood flow in west syndrome. Epilepsia. 1993;34(4):707–715.
   PubMed Web of Science ®Google Scholar
• Traub RD, Moeller F, Rosch R, et al. Seizure initiation in infantile spasms vs. focal seizures: proposed common cellular mechanisms. Rev Neurosci. 2020;31(2):181–200.
   PubMed Web of Science ®Google Scholar
• Carracedo LM, Kjeldsen H, Cunnington L, et al. A neocortical delta rhythm facilitates reciprocal interlaminar interactions via nested theta rhythms. J Neurosci. 2013;33(26):10750–10761.
   PubMed Web of Science ®Google Scholar
• Hall SP, Traub RD, Adams NE, et al. Enhanced interlaminar excitation or reduced superficial layer inhibition in neocortex generates different spike-and-wave-like electrographic events in vitro. J Neurophysiol. 2018;119(1):49–61.
   PubMed Web of Science ®Google Scholar
• Brunson KL, Eghbal-Ahmadi M, Baram TZ. How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis. Brain Dev. 2001;23(7):533–538.
   PubMed Web of Science ®Google Scholar
• Janicot R, Shao L-R, Stafstrom CE. Infantile spasms: an update on pre-clinical models and EEG mechanisms. Children. 2020;7(1):5.
   Google Scholar
• Kabova R, Liptakova S, Slamberova R, et al. Age-specific N-Methyl-D-aspartate-induced seizures: perspectives for the west syndrome model. Epilepsia. 1999;40(10):1357–1369.
   PubMed Web of Science ®Google Scholar
• Iacobaş DA, Chachua T, Iacobaş S, et al. ACTH and PMX53 recover synaptic transcriptome alterations in a rat model of infantile spasms. Sci Rep. 2018;8(1):5722.
   PubMedGoogle Scholar
• Baram TZ. Go “West,” Young Man … the quest for animal models of infantile spasms (West Syndrome). Epilepsy Curr. 2007;7(6):165–167.
   PubMedGoogle Scholar
• Kwon HH, Neupane C, Shin J, et al. Calpain-2 as a treatment target in prenatal stress-induced epileptic spasms in infant rats. Exp Neurobiol. 2019;28(4):529–536.
   PubMed Web of Science ®Google Scholar
• Chern C-R, Chern C-J, Velíšková J, et al. AQB-565 shows promise in preclinical testing in the model of epileptic spasms during infancy: head-to-head comparison with ACTH. Epilepsy Res. 2019;152:31–34.
   PubMed Web of Science ®Google Scholar
• Fuchs C, Gennaccaro L, Trazzi S, et al. Heterozygous CDKL5 knockout female mice are a valuable animal model for CDKL5 disorder. Neural Plast. 2018;2018:1–18.
   Web of Science ®Google Scholar
• Joshi K, Shen L, Cao F, et al. Kcnj6 (GIRK2) trisomy is not sufficient for conferring the susceptibility to infantile spasms seen in the Ts65Dn mouse model of down syndrome. Epilepsy Res. 2018;145:82–88.
   PubMed Web of Science ®Google Scholar
• Kato M, Dobyns WB. X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, “interneuronopathy.”. J Child Neurol. 2005;20(4):392–397.
   PubMed Web of Science ®Google Scholar
• Marsh E, Fulp C, Gomez E, et al. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain. 2009;132(6):1563–1576.
   PubMed Web of Science ®Google Scholar
• Price MG, Yoo JW, Burgess DL, et al. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci. 2009;29(27):8752–8763.
   PubMed Web of Science ®Google Scholar
• Olivetti PR, Maheshwari A, Noebels JL. Neonatal Estradiol stimulation prevents epilepsy in arx model of x-linked infantile spasms syndrome. Sci Transl Med. 2014;6(220):220ra12.
   PubMed Web of Science ®Google Scholar
• Cortez MA, Shen L, Wu Y, et al. Infantile spasms and down syndrome: a new animal model. Pediatr Res. 2009;65(5):499–503.
   PubMed Web of Science ®Google Scholar
• Harashima C, Jacobowitz DM, Witta J, et al. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: A model of Down syndrome. J Comp Neurol. 2006;494(5):815–833.
   PubMed Web of Science ®Google Scholar
• Pirone A, Alexander J, Lau LA, et al. APC conditional knock-out mouse is a model of infantile spasms with elevated neuronal β-catenin levels, neonatal spasms, and chronic seizures. Neurobiol Dis. 2017;98:149–157.
   PubMed Web of Science ®Google Scholar
• Baram TZ, Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Dev Brain Res. 1991;61(1):97–101.
   PubMedGoogle Scholar
• Brunson KL, Khan N, Eghbal-Ahmadi M, et al. Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression. Ann Neurol. 2001;49(3):304–312.
   PubMed Web of Science ®Google Scholar
• Frost JD, Le JT, Lee CL, et al. Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms. Neurobiol Dis. 2015;82:1–11.
   PubMed Web of Science ®Google Scholar
• Lee CL, Frost JD, Swann JW, et al. A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia. 2008;49(2):298–307.
   PubMed Web of Science ®Google Scholar
• Chachua T, Yum M-S, Velíšková J, et al., Validation of the rat model of cryptogenic infantile spasms. Epilepsia. 2011;52(9):1666–1677. .
   PubMed Web of Science ®Google Scholar
• Shi X, Zou L-P, Yang G, et al. Prenatal stress exposure hypothesis for infantile spasms. Med Hypotheses. 2012;78(6):735–737.
   PubMed Web of Science ®Google Scholar
• Stafstrom CE. Infantile spasms: a critical review of emerging animal models. Epilepsy Curr. 2009;9(3):75–81.
   PubMed Web of Science ®Google Scholar
• Galanopoulou AS, Mowrey WB, Liu W, et al. Preclinical screening for treatments for infantile spasms in the multiple hit rat model of infantile spasms: an update. Neurochem Res. 2017;42(7):1949–1961.
   PubMed Web of Science ®Google Scholar
• Ono T, Moshé SL, Galanopoulou AS. Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms. Epilepsia. 2011;52(9):1678–1684.
   PubMed Web of Science ®Google Scholar
• Briggs SW, Mowrey W, Hall CB, et al. CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms. Epilepsia. 2014;55(1):94–102.
   PubMed Web of Science ®Google Scholar
• Galanopoulou AS. Basic mechanisms of catastrophic epilepsy – overview from animal models. Brain Dev. 2013;35(8):748–756.
   PubMed Web of Science ®Google Scholar
• Scantlebury MH, Galanopoulou AS, Chudomelova L, et al. A model of symptomatic infantile spasms syndrome. Neurobiol Dis. 2010;37(3):604–612.
   PubMed Web of Science ®Google Scholar
• Berg AT, Chakravorty S, Koh S, et al. Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms. Biagini G, editor. PLoS One. 2018;13(3):e0193599.
   PubMed Web of Science ®Google Scholar
• Inoue T, Shimizu M, Hamano S, et al. Epilepsy and West syndrome in neonates with hypoxic-ischemic encephalopathy. Pediatr Int. 2014;56(3):369–372.
   PubMed Web of Science ®Google Scholar
• Guggenheim MA, Frost JD, Hrachovy RA. Time interval from a brain insult to the onset of infantile spasms. Pediatr Neurol. 2008;38(1):34–37.
   PubMed Web of Science ®Google Scholar
• Ross ME. Brain malformations, epilepsy, and infantile spasms. Int Rev Neurobiol. 2002;49:333–352.
   PubMed Web of Science ®Google Scholar
• Mastrangelo M. Novel genes of early-onset epileptic encephalopathies: from genotype to phenotypes. Pediatr Neurol. 2015;53(2):119–129.
   PubMed Web of Science ®Google Scholar
• Esmaeeli Nieh S, Sherr EH. Epileptic encephalopathies: new genes and new pathways. Neurotherapeutics. 2014;11(4):796–806.
   PubMed Web of Science ®Google Scholar
• Sharma S, Prasad AN. Genetic testing of epileptic encephalopathies of infancy: an approach. J Can Des Sci Neurol. 2013;40(1):10–16.
   PubMed Web of Science ®Google Scholar
• Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45(6):355–367.
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Kidokoro H, Ogawa C, et al. Longitudinal Findings of MRI and PET in west syndrome with subtle focal cortical dysplasia. Am J Neuroradiol. 2018;39(10):1932–1937.
   PubMed Web of Science ®Google Scholar
• Osborne JP, Edwards SW, Dietrich Alber F, et al., The underlying etiology of infantile spasms (West syndrome): information from the International Collaborative Infantile Spasms Study (ICISS). Epilepsia. 2019;60(9):1861–1869. .
   PubMed Web of Science ®Google Scholar
• Dulac O. What is West syndrome? Brain Dev. 2001;23(7):447–452.
   PubMed Web of Science ®Google Scholar
• Michaud JL, Lachance M, Hamdan FF, et al., The genetic landscape of infantile spasms. Hum Mol Genet. 2014;23(18):4846–4858. .
   PubMed Web of Science ®Google Scholar
• Fusco L, Chiron C, Trivisano M, et al. Infantile Spasms. In:Bureau M, Genton P, Dravet C, et al. editors. Epileptic syndr. infancy child. adolesc. 6th ed. Montrouge, France: John Libbey Eurotext. 2019. 103–118.
   Google Scholar
• Mei D, Parrini E, Marini C, et al. The Impact of next-generation sequencing on the diagnosis and treatment of epilepsy in paediatric patients. Mol Diagn Ther. 2017;21(4):357–373.
   PubMed Web of Science ®Google Scholar
• Widjaja E, Go C, McCoy B, et al. Neurodevelopmental outcome of infantile spasms: A systematic review and meta-analysis. Epilepsy Res. 2015;109:155–162.
   PubMed Web of Science ®Google Scholar
• Salar S, Moshé SL, Galanopoulou AS. Metabolic etiologies in West syndrome. Epilepsia Open. 2018;3:134–166.
   PubMedGoogle Scholar
• Riikonen R. Long-term outcome of patients with West syndrome. Brain Dev. 2001;23(7):683–687.
   PubMed Web of Science ®Google Scholar
• Lux AL, Edwards SW, Hancock E, et al., The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4(11):712–717. .
   PubMed Web of Science ®Google Scholar
• Darke K, Edwards SW, Hancock E, et al. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch Dis Child. 2010;95(5):382–386.
   PubMed Web of Science ®Google Scholar
• Primec ZR, Stare J, Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia. 2006;47(12):2202–2205.
   PubMed Web of Science ®Google Scholar
• O’Callaghan FJK, Lux AL, Darke K, et al., The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom infantile spasms study. Epilepsia. 2011;52(7):1359–1364. .
   PubMed Web of Science ®Google Scholar
• Dilber C, Çalışkan M, Sönmezoğlu K, et al. Positron emission tomography findings in children with infantile spasms and autism. J Clin Neurosci. 2013;20(3):373–376.
   PubMed Web of Science ®Google Scholar
• Riikonen R, Amnell G. Psychiatric disorders in children with earlier infantile spasms. Dev Med Child Neurol. 2008;23:747–760.
   Google Scholar
• Saemundsen E, Ludvigsson P, Rafnsson V. Autism spectrum disorders in children with a history of infantile spasms: a population-based study. J Child Neurol. 2007;22(9):1102–1107.
   PubMed Web of Science ®Google Scholar
• Saemundsen E, Ludvigsson P, Rafnsson V. Risk of autism spectrum disorders after infantile spasms: A population-based study nested in a cohort with seizures in the first year of life. Epilepsia. 2008;49(11):1865–1870.
   PubMed Web of Science ®Google Scholar
• Bitton JY, Demos M, Elkouby K, et al. Does treatment have an impact on incidence and risk factors for autism spectrum disorders in children with infantile spasms? Epilepsia. 2015;56(6):856–863.
   PubMed Web of Science ®Google Scholar
• Kelley SA, Knupp KG. Infantile spasms—have we made progress? curr Neurol Neurosci Rep. 2018;18(5):27.
   PubMed Web of Science ®Google Scholar
• Hrachovy RA, Frost JD, Kellaway P, et al., Double-blind study of ACTH vs prednisone therapy in infantile spasms. J Pediatr. 1983;103(4):641–645. .
   PubMed Web of Science ®Google Scholar
• Lux AL, Edwards SW, Hancock E, et al., The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004;364(9447):1773–1778. .
   PubMed Web of Science ®Google Scholar
• Chang Y, Chen C, Chen S, et al., Effectiveness of corticosteroids versus adrenocorticotropic hormone for infantile spasms: a systematic review and meta‐analysis. Ann Clin Transl Neurol. 2019;6(11):2270–2281. .
   PubMed Web of Science ®Google Scholar
• Chiron C, Dulac O, Beaumont D, et al. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol. 1991;6(2_suppl):2S52–2S59.
   Google Scholar
• Westall CA, Wright T, Cortese F, et al. Vigabatrin retinal toxicity in children with infantile spasms: an observational cohort study. Neurology. 2014;83(24):2262–2268.
   PubMed Web of Science ®Google Scholar
• Wheless JW, Carmant L, Bebin M, et al. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia. 2009;50(2):195–205.
   PubMed Web of Science ®Google Scholar
• Hussain SA, Tsao J, Li M, et al. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent. Epilepsia. 2017;58(4):674–682.
   PubMed Web of Science ®Google Scholar
• Li S, Zhong X, Hong S, et al. Prednisolone/prednisone as adrenocorticotropic hormone alternative for infantile spasms: a meta‐analysis of randomized controlled trials. Dev Med Child Neurol. 2020;62(5):575–580.
   PubMed Web of Science ®Google Scholar
• Zhang B, McDaniel SS, Rensing NR, et al. Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. fisone G, editor. PLoS One. 2013;8(2):e57445.
   PubMed Web of Science ®Google Scholar
• Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013;6:CD001770.
   PubMed Web of Science ®Google Scholar
• Askalan R, Mackay M, Brian J, et al. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. J Child Neurol. 2003;18(3):165–170.
   PubMed Web of Science ®Google Scholar
• Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: A prospective, randomized, blinded study. Pediatrics. 1996;97(3):375–379.
   PubMed Web of Science ®Google Scholar
• Bitton JY, Sauerwein HC, Weiss SK, et al., A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile spasms. Epilepsia. 2012;53(9):1570–1576. .
   PubMed Web of Science ®Google Scholar
• Gowda VK, Narayanaswamy V, Shivappa SK, et al. Corticotrophin-ACTH in comparison to prednisolone in west syndrome – a randomized study. Indian J Pediatr. 2019;86(2):165–170.
   PubMed Web of Science ®Google Scholar
• Wanigasinghe J, Arambepola C, Ranganathan SS, et al. Randomized, single-blind, parallel clinical trial on efficacy of oral prednisolone versus intramuscular corticotropin: a 12-month assessment of spasm control in west syndrome. Pediatr Neurol. 2017;76:14–19.
   PubMed Web of Science ®Google Scholar
• Dreifuss F. Infantile Spasms. Arch Neurol. 1986;43(11):1107.
   PubMedGoogle Scholar
• Zou L-P, Wang X, Dong C-H, et al. Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: A 24-week, randomized, open-label, follow-up study in China. Clin Ther. 2010;32(4):692–700.
   PubMed Web of Science ®Google Scholar
• Vigevano P, Cilio MR. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia. 1997;38(12):1270–1274.
   PubMed Web of Science ®Google Scholar
• Yanagaki S, Oguni H, Hayashi K, et al. A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev. 1999;21(7):461–467.
   PubMed Web of Science ®Google Scholar
• Türe E, Kamaşak T, Cora M, et al. Comparison of the serum cytokine levels before and after adrenocorticotropic hormone (ACTH) therapy in patients with infantile spasm. Seizure. 2016;41:112–115.
   PubMed Web of Science ®Google Scholar
• Hussain SA. Treatment of infantile spasms. Epilepsia Open. 2018;3(S2):143–154.
   PubMedGoogle Scholar
• O’Callaghan FJK, Edwards SW, Alber FD, et al., Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017;16(1):33–42. .
   PubMed Web of Science ®Google Scholar
• Chiron C, Dumas C, Jambaqué I, et al., Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997;26(2):389–395. .
   PubMed Web of Science ®Google Scholar
• Appleton RE, Peters ACB, Mumford JP, et al., Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia. 1999;40(11):1627–1633. .
   PubMed Web of Science ®Google Scholar
• Elterman RD, Shields WD, Bittman RM, et al. Vigabatrin for the treatment of infantile spasms: final report of a randomized trial. J Child Neurol. 2010;25(11):1340–1347.
   PubMed Web of Science ®Google Scholar
• O’Callaghan FJK, Edwards SW, Alber FD, et al. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolesc Heal. 2018;2(10):715–725.
   Web of Science ®Google Scholar
• Wolak J, Misra SN. Developmental outcomes of infants treated with combination therapy for infantile spasms. Pediatr Neurol Briefs. 2019;33: 2.
   PubMedGoogle Scholar
• Hussain SA, Schmid E, Peters JM, et al. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex. Epilepsy Res. 2018;148:1–7.
   PubMed Web of Science ®Google Scholar
• Hong AM, Turner Z, Hamdy RF, et al. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia. 2010;51(8):1403–1407.
   PubMed Web of Science ®Google Scholar
• Jr DR N, Kuroda MM, Carroll J, et al. Experience with the ketogenic diet in infants. Pediatrics. 2001;108(1):129–133.
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Pyzik PL, McGrogan JR, et al. Efficacy of the ketogenic diet for infantile spasms. Pediatrics. 2002;109(5):780–783.
   PubMed Web of Science ®Google Scholar
• Eun SH, Kang HC, Kim DW, et al. Ketogenic diet for treatment of infantile spasms. Brain Dev. 2006;28(9):566–571.
   PubMed Web of Science ®Google Scholar
• Prezioso G, Carlone G, Zaccara G, et al. Efficacy of ketogenic diet for infantile spasms: A systematic review. Acta Neurol. Scand. 2018;137(1):4–11.
   PubMed Web of Science ®Google Scholar
• Dressler A, Benninger F, Trimmel-Schwahofer P, et al., Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: A single-center parallel-cohort randomized controlled trial. Epilepsia. 2019;60(3):441–451. .
   PubMed Web of Science ®Google Scholar
• Mahmoud AA, Rizk TM, Mansy AA, et al. Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids: open labeled randomized prospective study. Neurosciences. 2013;18(2):143–146.
   PubMed Web of Science ®Google Scholar
• Glauser TA. Topiramate in the catastrophic epilepsies of childhood. J Child Neurol. 2000;15(1_suppl):S14–S21.
   PubMedGoogle Scholar
• Fox JR, Guido-Estrada N, Williams K, et al. Outcomes among patients with infantile spasms treated with hormonal therapy and adjuvant topiramate versus hormonal therapy alone. Epileptic Disord. 2020;22(1):33–38.
   PubMed Web of Science ®Google Scholar
• Hurst DL, Rolan TD. The use of felbamate to treat infantile spasms. J Child Neurol. 1995;10(2):134–136.
   PubMed Web of Science ®Google Scholar
• Cianchetti C, Pruna D, Coppola G, et al. Low-dose lamotrigine in West syndrome. Epilepsy Res. 2002;51(1–2):199–200.
   PubMed Web of Science ®Google Scholar
• Veggiotti P, Cieuta C, Rey E, et al. Lamotrigine in infantile spasms. Lancet. 1994;344(8933):1375–1376.
   PubMed Web of Science ®Google Scholar
• Lotze TE, Wilfong AA. Zonisamide treatment for symptomatic infantile spasms. Neurology. 2004;62(2):296–298.
   PubMed Web of Science ®Google Scholar
• Hussain SA, Navarro M, Heesch J, et al. Limited efficacy of zonisamide in the treatment of refractory infantile spasms. Epilepsia Open. 2020;5:121–126.
   PubMedGoogle Scholar
• Yanai S, Hanai T, Narazaki O. Treatment of infantile spasms with zonisamide. Brain Dev. 1999;21(3):157–161.
   PubMed Web of Science ®Google Scholar
• Hahn J, Lee H, Kang H-C, et al. Clobazam as an adjunctive treatment for infantile spasms. Epilepsy Behav. 2019;95:161–165.
   PubMed Web of Science ®Google Scholar
• Tibussek D, Klepper J, Korinthenberg R, et al. Treatment of infantile spasms: report of the interdisciplinary guideline committee coordinated by the german-speaking society for neuropediatrics. Neuropediatrics. 2016;47(3):139–150.
   PubMed Web of Science ®Google Scholar
• Herlopian A, Hess EJ, Barnett J, et al. Cannabidiol in treatment of refractory epileptic spasms: an open-label study. Epilepsy Behav. 2020;106:106988.
   PubMed Web of Science ®Google Scholar
• Tsai J, Pellock JM, Hehn J, et al. A double‐blind, placebo‐controlled, dose‐ranging clinical study to evaluate the safety, tolerability, and antiepileptic activity of ganaxolone in treatment of patients with infantile spasms. Neurology. 2009;72(11 Suppl 3):A119.
   Web of Science ®Google Scholar
• Barba C, Mai R, Grisotto L, et al. Unilobar surgery for symptomatic epileptic spasms. Ann Clin Transl Neurol. 2017;4(1):36–45.
   PubMed Web of Science ®Google Scholar
• Chugani HT, Shields WD, Shewmon DA, et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol. 1990;27(4):406–413.
   PubMed Web of Science ®Google Scholar
• Kang JW, Rhie SK, Yu R, et al. Seizure outcome of infantile spasms with focal cortical dysplasia. Brain Dev. 2013;35(8):816–820.
   PubMed Web of Science ®Google Scholar
• Chugani HT, Ilyas M, Kumar A, et al. Surgical treatment for refractory epileptic spasms: the Detroit series. Epilepsia. 2015;56(12):1941–1949.
   PubMed Web of Science ®Google Scholar
• Lee Y-J, Kim E-H, Yum M-S, et al. Long-term outcomes of hemispheric disconnection in pediatric patients with intractable epilepsy. J Clin Neurol. 2014;10(2):101–107.
   PubMed Web of Science ®Google Scholar
• Jonas R, Asarnow RF, LoPresti C, et al. Surgery for symptomatic infant-onset epileptic encephalopathy with and without infantile spasms. Neurology. 2005;64:746–750.
   PubMed Web of Science ®Google Scholar
• Chipaux M, Dorfmüller G, Fohlen M, et al. Refractory spasms of focal onset—A potentially curable disease that should lead to rapid surgical evaluation. Seizure. 2017;51:163–170.
   PubMed Web of Science ®Google Scholar
• Neal A, Ostrowsky‐Coste K, Jung J, et al. Epileptogenicity in tuberous sclerosis complex: A stereoelectroencephalographic study. Epilepsia. 2020;61(1):81–95.
   PubMed Web of Science ®Google Scholar
• de Palma L, Pietrafusa N, Gozzo F, et al. Outcome after hemispherotomy in patients with intractable epilepsy: comparison of techniques in the Italian experience. Epilepsy Behav. 2019;93:22–28.
   PubMed Web of Science ®Google Scholar
• Baba H, Toda K, Ono T, et al. Surgical and developmental outcomes of corpus callosotomy for West syndrome in patients without MRI lesions. Epilepsia. 2018;59(12):2231–2239.
   PubMed Web of Science ®Google Scholar
• Okanishi T, Fujimoto A, Nishimura M, et al. Insufficient efficacy of vagus nerve stimulation for epileptic spasms and tonic spasms in children with refractory epilepsy. Epilepsy Res. 2018;140:66–71.
   PubMed Web of Science ®Google Scholar
• Nabbout R, Belousova E, Benedik MP, et al. Epilepsy in tuberous sclerosis complex: findings from the TOSCA Study. Epilepsia Open. 2019;4(1):73–84.
   PubMedGoogle Scholar
• Chu-Shore CJ, Major P, Camposano S, et al. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2009;51(7):1236–1241.
   PubMed Web of Science ®Google Scholar
• Dragoumi P, O’Callaghan F, Zafeiriou DI. Diagnosis of tuberous sclerosis complex in the fetus. Eur J Paediatr Neurol. 2018;22(6):1027–1034.
   PubMed Web of Science ®Google Scholar
• Wu JY, Goyal M, Peters JM, et al. Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study. Epilepsia. 2019;60(12):2428–2436.
   PubMed Web of Science ®Google Scholar
• Curatolo P, Franz DN, Lawson JA, et al. Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial. Lancet Child Adolesc Heal. 2018;2(7):495–504.
   Web of Science ®Google Scholar
• Jozwiak S, Słowińska M, Borkowska J, et al. Preventive antiepileptic treatment in tuberous sclerosis complex: a long-term, prospective trial. Pediatr Neurol. 2019;101:18–25.
   PubMed Web of Science ®Google Scholar
• van der Poest Clement E, Jansen FE, Braun KPJ, et al. Update on drug management of refractory epilepsy in tuberous sclerosis complex. Pediatr Drugs. 2020;22(1):73–84.
   PubMed Web of Science ®Google Scholar
• Tiwari VN, Sundaram SK, Chugani HT, et al. Infantile spasms are associated with abnormal copy number variations. J Child Neurol. 2013;28(10):1191–1196.
   PubMed Web of Science ®Google Scholar
• Mignot C, Moutard M-L, Trouillard O, et al. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients. Epilepsia. 2011;52(10):1820–1827.
   PubMed Web of Science ®Google Scholar
• Lemke JR, Hendrickx R, Geider K, et al. GRIN2B mutations in west syndrome and intellectual disability with focal epilepsy. Ann Neurol. 2014;75(1):147–154.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu Z, Lin Z, et al. De novo germline mutations in SEMA5A associated with infantile spasms. Front Genet. 2019;10:605.
   PubMed Web of Science ®Google Scholar
• Nardello R, Fontana A, Antona V, et al. A novel mutation of WDR62 gene associated with severe phenotype including infantile spasm, microcephaly, and intellectual disability. Brain Dev. 2018;40(1):58–64.
   PubMed Web of Science ®Google Scholar
• Barcia G, Chemaly N, Kuchenbuch M, et al. Epilepsy with migrating focal seizures: KCNT1 mutation hotspots and phenotype variability. Neurol Genet. 2019;5(6):e363.
   PubMed Web of Science ®Google Scholar
• Jia Y, Lin Y, Li J, et al. Quinidine therapy for lennox-gastaut syndrome with KCNT1 mutation. A case report and literature review. Front Neurol. 2019;10:64.
   PubMed Web of Science ®Google Scholar
• Platzer K, Yuan H, Schütz H, et al. GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects. J Med Genet. 2017;54(7):460–470.
   PubMed Web of Science ®Google Scholar
• Messer R, Knupp KG. Infantile Spasms: opportunities to improve care. Semin Neurol. 2020;40(2):236–245.
   PubMed Web of Science ®Google Scholar
• Ito M, Aiba H, Hashimoto K, et al. Low-dose ACTH therapy for West syndrome: initial effects and long-term outcome. Neurology. 2002;58(1):110–114.
   PubMed Web of Science ®Google Scholar
• Wang Y-J, Zhang Y, Liang X-H, et al. Effects of adrenal dysfunction and high-dose adrenocorticotropic hormone on NMDA-induced spasm seizures in young Wistar rats. Epilepsy Res. 2012;100(1–2):125–131.
   PubMed Web of Science ®Google Scholar